Loading...
The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
New oral anticoagulants (NOACs; ie, direct thrombin inhibitor [DTI] and factor Xa [FXa] inhibitors) were used as alternatives to warfarin. Specific antidotes (idarucizumab for dabigatran and andexanet alfa for FXa inhibitors) and hemostatic reversal agents were used for lowering bleeding, but their...
Na minha lista:
| Udgivet i: | Clin Appl Thromb Hemost |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714855/ https://ncbi.nlm.nih.gov/pubmed/30176738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029618796339 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|